In Versata Software v. Ford, the Federal Circuit reinstated $82.3M in damages and held that DTSA plaintiffs may elect unjust enrichment damages by statutory right.
US biotech firm Agensys has filed suit in California, accusing Suzhou Zelgen, Shanghai Zelgen, Gensun Biopharma, and Sheng of misappropriating its proprietary LRRC15 antibody technology to support a series of patent applications.
In A.L.M. v. Zydex, the Federal Circuit reversed a dismissal for lack of standing and held that patent owners retaining enforcement and royalty rights have Article III standing.
In Magnolia Medical v. Kurin, USPTO Director John Squires denied IPR institution and used the decision to lay out the factors he will weigh in future discretionary denial calls.
